Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Computer Science (1)
- (-) Neutron Science (3)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (4)
- Bioenergy (1)
- Decarbonization (1)
- Fusion (1)
- Isotopes (3)
- Molten Salt (3)
- Nuclear Energy (10)
- Space Exploration (1)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Oak Ridge National Laboratory researchers working on neutron imaging capabilities for nuclear materials have developed a process for seeing the inside of uranium particles – without cutting them open.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.